Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/20/2025 6:04:49 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 11616
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49743
I wish. That would make me a big winner. Then I
Squar
10/11/2018 1:48:19 PM
49742
Hey Squar you know TheBunny over at your main
(2)
smokenhot
10/11/2018 1:43:50 PM
49741
I going to be more than happy to sell those
(1)
Loose Lips
10/11/2018 1:42:54 PM
49740
Let me fix that for you. You meant to write "I
(2)
Drano
10/11/2018 1:35:56 PM
49739
Yeesh....I bought shares at 3.40. Now that's a
Squar
10/11/2018 1:35:04 PM
49738
Those might be some of the shares I bought. My
(2)
Loose Lips
10/11/2018 12:56:11 PM
49737
Daubers it's known we are waiting on BTD
smokenhot
10/11/2018 12:43:59 PM
49736
Agree that we have raised $ and should at least
(2)
zdubble17
10/11/2018 12:43:12 PM
49735
I go agree. Ive now added over 60K shares
(1)
DaubersUP
10/11/2018 12:36:59 PM
49734
DaubersUP even at 16 million shares, that is only
(1)
zdubble17
10/11/2018 12:14:59 PM
49733
Alan. We need a deal or some kind of promising
(1)
DaubersUP
10/11/2018 12:06:00 PM
49732
Volume was around 500k but has flatlined for
Drano
10/11/2018 11:39:30 AM
49731
At 11:30 or two hours into the trading day volume
AlanC
10/11/2018 11:33:54 AM
49730
I would buy the .17's and consider yourself
(3)
AlanC
10/11/2018 9:57:08 AM
49729
The financing deal put my solvency concerns to
(1)
Squar
10/11/2018 9:53:55 AM
49728
Convinced me to pick up a bit more here Zdub.
Squar
10/11/2018 9:51:30 AM
49727
Good point. I have always felt that as painful as
(4)
Loose Lips
10/11/2018 9:50:53 AM
49726
It is what it is.
Kelt
10/11/2018 9:16:58 AM
49725
Sub penny thoughts are a bunch of nonsense. That
scgmck1
10/11/2018 8:59:45 AM
49724
I think what cracks me up is that this company
(11)
zdubble17
10/11/2018 8:50:52 AM
49723
yeah that will show the crooks. I got my sub
(2)
Jimmyboy
10/11/2018 8:49:04 AM
49722
If they are foolish enough do that, they will
(2)
scgmck1
10/11/2018 8:36:33 AM
49721
Really? Squar don't show your motive that easy.
zdubble17
10/11/2018 8:28:11 AM
49720
Anyone have a guess on trading? Are 0.17s the buy
(2)
Squar
10/11/2018 7:58:02 AM
49719
Priority review accompanying BTD for B-OM - yes.
(1)
Squar
10/10/2018 10:13:29 PM
49718
Included in it is "Material threat medical
(1)
Squar
10/10/2018 10:08:50 PM
49717
DaubersUp in the Swamp had a good post. Yes there
(6)
Trading Pro Broker
10/10/2018 8:55:06 PM
49716
Priority Review could/would be used in the
Kelt
10/10/2018 8:49:09 PM
49715
This is the list of criteria for a drug to meet
(2)
Kelt
10/10/2018 8:43:51 PM
49714
42% marked today and this does not include the
(1)
AlanC
10/10/2018 5:46:54 PM
49713
PRV is usually awarded for Orphan Drug
(1)
Squar
10/10/2018 5:35:10 PM
49712
IPIX pre market (t trades) today .. 09:29:22 0.20
(2)
4kids
10/10/2018 5:22:28 PM
49711
That is what I think as well.
Trading Pro Broker
10/10/2018 4:12:43 PM
49710
Another thought is that in order to secure the
(4)
Kelt
10/10/2018 4:10:09 PM
49709
Another good resource regarding PRV.
scgmck1
10/10/2018 3:31:49 PM
49708
"When seeking approval for a drug, manufacturers
(1)
Drano
10/10/2018 2:06:25 PM
49707
Drano,DoubleJ123 or any long term member here
(3)
Kelt
10/10/2018 1:58:10 PM
49706
I bet BTD was submitted when term sheet was
(4)
smokenhot
10/10/2018 1:54:09 PM
49705
The FDA will respond in 14 days for Type B (EOP)
(4)
sox0407
10/10/2018 1:49:56 PM
49704
The way the market loks some would think the sky
(3)
BooDog
10/10/2018 1:36:19 PM
49702
Trading just dried up. No trades for quite a
Drano
10/10/2018 1:06:08 PM
49701
With the position you're amassing in IPIX, pretty
Drano
10/10/2018 12:48:05 PM
49700
One thing I have noticed is that Leo and Art just
(4)
Chemdeps
10/10/2018 12:34:05 PM
49699
Very well could be Alan. Certainly putting the
(1)
BooDog
10/10/2018 12:17:12 PM
49698
That's a good point. It could be that someone is
(2)
Drano
10/10/2018 12:03:50 PM
49697
I just want to speculate a bit...maybe this
(3)
doubleJ23
10/10/2018 12:00:49 PM
49696
I think Leo is working a carefully crafted plan
(4)
AlanC
10/10/2018 11:53:03 AM
49695
We know the "Level 2" is not accurate. But
(2)
Drano
10/10/2018 11:48:00 AM
49694
Here's the Edgar (gov) link directly to the 8-K
Drano
10/10/2018 11:39:32 AM
49693
That sounds right to me. I have to think Co.
doubleJ23
10/10/2018 11:31:47 AM
Newer
Older
Recent Articles
Former CIA Officer Discusses AI Project Impact on America
Elliott Investment Management's Support for Workday's Future
The Journey of a $1000 Microsoft Investment Over 20 Years
Clorox Company Announces New Quarterly Dividend of $1.24
Savara Inc. Investors Get Opportunity for Class Action Suit
Investors Take Action in Lockheed Martin Securities Case
Investigation Launch by Rosen Law for Encompass Health Investors
Elliott Investment Management's Progressive Outlook on Workday
Landmark Study Highlights NobleStitch™ PFO Closure Benefits
Nxera Pharma Advances Immunotherapy Research in Cancer Clinical Trial
Western Forest Products Secures New US$30 Million Credit Facility
Western Forest Products Secures a New $30 Million Credit Facility
Discover the Growth Potential of Progressive Investments
Altimmune Investors Urged to Act Before Class Action Deadline
Revolutionizing Storytelling: Verily Storyworks Emerges
Breakthrough Results from ASC30 Study Unveiled at EASD Meeting
Navigating Opportunities in Recent Sable Offshore Corp. Lawsuit
Eisai's Etalanetug Tau Antibody Receives FDA Fast Track Status
Investors Stand United in LifeMD Securities Fraud Case
Exciting Developments in StubHub's Initial Public Offering
Brookfield Global Infrastructure Fund Declares Quarterly Dividend
Fly-E Group Faces Important Class Action Deadline for Investors
The Growth Journey of Dell Technologies Stock Over Five Years
Veteran Author Fosters Community Connections Through Book Event
Brookfield Announces Quarterly Distribution for Investors
Launched Investigation into Lesaka Technologies for Shareholders
Legal Guidance for CTO Realty Growth Investors Ahead of Deadline
A Remarkable Journey: The Growth of Starbucks Over 20 Years
Investors Have a Chance to Lead the Snap Inc. Lawsuit
Innovative Hair Care Solutions from Magic Sleek for All Types
Navigating Retirement: Rediscovering Purpose Beyond Work
How a $1000 Investment in OSI Systems Could Flourish
How $1000 in Cencora Became Over $6000 in Just 10 Years
Onyx Gold Secures $15 Million in Strategic Financing Deal
Investors Alert: Unicoin, Inc. Class Action Investigation
Honoring Ryan Silver: A Leader in College Basketball Impact
Leadership Changes at NanoXplore: A New Chapter Begins
SelectQuote's Legal Challenges: What Investors Should Know
G-P Recognized as a Pioneering Leader in EOR Solutions
KinderCare Faces Legal Challenges Amid Child Safety Allegations
Court's Ruling Protects Ontario's Water Supply from IEUA Deal
Celebrating Leadership Excellence: David M. Sullivan II's Impact
Celebrating Dr. Erica S. Becker: A Leading Oral Surgeon
How Supplier Onboarding Shapes Long-Term Business Relationships
Rosen Law Firm Urges Snap Inc. Investors to Take Action
aTyr Pharma's Share Turmoil: Investigating the Miscommunication
Turning Small Investments into Substantial Returns: F5's Journey
Exploring BlackRock's Transition of Mutual Funds to ETFs
How $100 in Lam Research Became a Remarkable Investment
LifeMD Faces Class Action Lawsuit Over Misleading Claims